AxoGen (AXGN) News Today $13.95 -0.05 (-0.36%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period AxoGen (AXGN) to Release Earnings on ThursdayAxoGen (NASDAQ:AXGN) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639574)October 31 at 5:31 AM | marketbeat.comSemanteon Capital Management LP Acquires Shares of 43,016 AxoGen, Inc. (NASDAQ:AXGN)Semanteon Capital Management LP bought a new position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 43,016 shares of the medical equipment pOctober 29, 2024 | marketbeat.comLeerink Partnrs Brokers Cut Earnings Estimates for AxoGenAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Equities research analysts at Leerink Partnrs reduced their FY2028 EPS estimates for AxoGen in a research note issued to investors on Tuesday, October 15th. Leerink Partnrs analyst M. Kratky now anticipates that the medical equipment provider will post eOctober 18, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Shares Down 4.3% - What's Next?AxoGen (NASDAQ:AXGN) Shares Down 4.3% - What's Next?October 17, 2024 | marketbeat.comExchange Traded Concepts LLC Reduces Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Exchange Traded Concepts LLC lowered its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 49.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 74,742 shares of the medical equipment provider's stock after seOctober 17, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 52-Week High - What's Next?AxoGen (NASDAQ:AXGN) Reaches New 1-Year High - Time to Buy?October 16, 2024 | marketbeat.comStockNews.com Upgrades AxoGen (NASDAQ:AXGN) to "Buy"StockNews.com upgraded AxoGen from a "hold" rating to a "buy" rating in a research note on Tuesday.October 15, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Millennium Management LLCMillennium Management LLC trimmed its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 48.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 681,755 shares of the medical equipment provideOctober 13, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Large Drop in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 1,210,000 shares, a decline of 25.8% from the September 15th total of 1,630,000 shares. Based on an average trading volume of 439,100 shares, the days-to-cover ratio is currently 2.8 days.October 12, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Sees Strong Trading Volume - Here's What HappenedAxoGen (NASDAQ:AXGN) Sees Strong Trading Volume - What's Next?October 11, 2024 | marketbeat.comSquarepoint Ops LLC Buys 39,624 Shares of AxoGen, Inc. (NASDAQ:AXGN)Squarepoint Ops LLC lifted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 186.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 60,913 shares of the medical equipment provider's stock after acOctober 10, 2024 | marketbeat.comAxogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...October 9, 2024 | finance.yahoo.comAxogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%October 8, 2024 | finance.yahoo.comAxogen (NASDAQ:AXGN) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comAxoGen (NASDAQ:AXGN) Trading Down 5.9%AxoGen (NASDAQ:AXGN) Shares Down 5.9%October 3, 2024 | marketbeat.comPerceptive Advisors LLC Lowers Holdings in AxoGen, Inc. (NASDAQ:AXGN)Perceptive Advisors LLC lessened its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 98.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,421 shares of the medical equipment proviSeptember 30, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 17.7% in SeptemberAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totalling 1,630,000 shares, a decrease of 17.7% from the August 31st total of 1,980,000 shares. Based on an average trading volume of 446,700 shares, the short-interest ratio is currently 3.6 days.September 28, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Given Average Recommendation of "Buy" by BrokeragesAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) has received a consensus rating of "Buy" from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokSeptember 28, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Upgraded by StockNews.com to BuyStockNews.com raised shares of AxoGen from a "hold" rating to a "buy" rating in a report on Wednesday.September 25, 2024 | marketbeat.comZacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGenSeptember 24, 2024 | finance.yahoo.comFirst Light Asset Management LLC Purchases 2,578,147 Shares of AxoGen, Inc. (NASDAQ:AXGN)First Light Asset Management LLC boosted its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 336.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,344,033 shares of the medical equipment provideSeptember 24, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Stock Holdings Lifted by Divisadero Street Capital Management LPDivisadero Street Capital Management LP lifted its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 587.2% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 686,994 shares of the medical equipment provider's stock after acqSeptember 20, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 12-Month High at $15.08AxoGen (NASDAQ:AXGN) Sets New 12-Month High at $15.08September 18, 2024 | marketbeat.comAxoGen: An Intriguing Growth StorySeptember 17, 2024 | seekingalpha.comAxoGen (NASDAQ:AXGN) Rating Increased to Buy at StockNews.comStockNews.com raised AxoGen from a "hold" rating to a "buy" rating in a report on Tuesday.September 17, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 1-Year High at $13.52AxoGen (NASDAQ:AXGN) Sets New 12-Month High at $13.52September 12, 2024 | marketbeat.comRice Hall James & Associates LLC Grows Position in AxoGen, Inc. (NASDAQ:AXGN)Rice Hall James & Associates LLC increased its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 26.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 194,269 shares of the medical equipment provSeptember 12, 2024 | marketbeat.comArrowMark Colorado Holdings LLC Reduces Stake in Axogen IncSeptember 12, 2024 | finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?September 11, 2024 | finance.yahoo.comAxoGen (NASDAQ:AXGN) Rating Lowered to Hold at StockNews.comStockNews.com cut AxoGen from a "buy" rating to a "hold" rating in a report on Monday.September 9, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Sets New 1-Year High at $13.35AxoGen (NASDAQ:AXGN) Sets New 1-Year High at $13.35September 6, 2024 | marketbeat.comAxogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®September 6, 2024 | globenewswire.comAxogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)September 4, 2024 | markets.businessinsider.comAxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Buy" by AnalystsAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) has earned an average recommendation of "Buy" from the five brokerages that are presently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation. The average 1-year price objective amongSeptember 3, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Large Decline in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) saw a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 1,800,000 shares, a decrease of 8.2% from the July 31st total of 1,960,000 shares. Based on an average trading volume of 435,200 shares, the days-to-cover ratio is presently 4.1 days.September 2, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Panagora Asset Management Inc.Panagora Asset Management Inc. lessened its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 21.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 292,214 shares of the medical equipment provider's stock after selling 81,023 shares during the period. PanaAugust 31, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Sets New 12-Month High at $13.20AxoGen (NASDAQ:AXGN) Reaches New 1-Year High at $13.20August 29, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 1-Year High at $13.03AxoGen (NASDAQ:AXGN) Reaches New 52-Week High at $13.03August 22, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $9.49 Million Holdings in AxoGen, Inc. (NASDAQ:AXGN)Assenagon Asset Management S.A. grew its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 2,014.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,310,811 shares of the medical equipment provider's stockAugust 17, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 52-Week High at $11.57AxoGen (NASDAQ:AXGN) Reaches New 52-Week High at $11.57August 16, 2024 | marketbeat.comAXGN Sep 2024 15.000 call (AXGN240920C00015000)August 14, 2024 | finance.yahoo.comVanguard Group Inc. Sells 54,093 Shares of AxoGen, Inc. (NASDAQ:AXGN)Vanguard Group Inc. trimmed its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 2.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,411,403 shares of the medical equipment provider'August 12, 2024 | marketbeat.comAxoGen Second Quarter 2024 Earnings: Beats ExpectationsAugust 11, 2024 | nz.finance.yahoo.comBuy Rating Affirmed for AxoGen: Strong Q2 Performance and Strategic Leadership Amidst Market Growth PotentialAugust 10, 2024 | markets.businessinsider.comAxoGen (NASDAQ:AXGN) Upgraded at StockNews.comStockNews.com upgraded AxoGen from a "hold" rating to a "buy" rating in a research note on Friday.August 9, 2024 | marketbeat.comBuy Rating Affirmed for AxoGen Amid Strong Q2 Performance and Positive Growth OutlookAugust 9, 2024 | markets.businessinsider.comApple, Inc. (AXGN) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comAxoGen, Inc. (NASDAQ:AXGN) Receives Average Rating of "Buy" from AnalystsShares of AxoGen, Inc. (NASDAQ:AXGN - Get Free Report) have been given a consensus rating of "Buy" by the four research firms that are currently covering the company, Marketbeat reports. Four research analysts have rated the stock with a buy rating. The average twelve-month target price among brokAugust 9, 2024 | marketbeat.comAxogen, Inc. Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 | markets.businessinsider.comAxogen, Inc. Announces New Leadership AppointmentsAugust 8, 2024 | globenewswire.com Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here AXGN Media Mentions By Week AXGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼0.560.43▲Average Medical News Sentiment AXGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼22▲AXGN Articles Average Week Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CUTR News IART News IRTC News ENOV News TNDM News CNMD News RXST News SLNO News NVCR News WRBY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
